Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab

被引：0
|
作者：
Deniz Tural
Ömer Fatih Ölmez
Ahmet Taner Sümbül
Nail Özhan
Burcu Çakar
Osman Köstek
Meltem Ekenel
Mustafa Erman
Hasan Şenol Coşkun
Fatih Selçukbiricik
Özge Keskin
Fatma Paksoy Türköz
Kerem Oruç
Selami Bayram
İrem Bilgetekin
Birol Yıldız
Mehmet Ali Nahit Şendur
Nail Paksoy
Ahmet Dirican
Dilek Erdem
Meltem Selam
Özgür Tanrıverdi
Semra Paydaş
Zuhat Urakçı
Elif Atağ
Sabri Güncan
Yüksel Ürün
Ali Alkan
Ali Osman Kaya
Deniz Tataroğlu Özyükseler
Halil Taşkaynatan
Mustafa Yıldırım
Müge Sönmez
Tuğba Başoğlu
Şeyda Gündüz
Saadettin Kılıçkap
Mehmet Artaç
机构：
[1] Bakirkoy Dr. Sadi Konuk Training and Research Hospital,Department of Medical Oncology
[2] Medipol University Hospital,Medical Oncology
[3] Baskent University Medical Faculty,Medical Oncology
[4] Pamukkale University Medical Faculty,Medical Oncology
[5] Ege University Medical Faculty,Medical Oncology
[6] Trakya University Medical Faculty,Medical Oncology
[7] Istanbul University Institute of Oncology,Medical Oncology
[8] Hacettepe University Medical Faculty,Medical Oncology
[9] Akdeniz University Medical Faculty,Medical Oncology
[10] Koc University Medical Faculty,Medical Oncology
[11] Selcuk University Medical Faculty,Medical Oncology
[12] Istinye Universty,Medical Oncology
[13] MedicalPark Goztepe Hospital,Medical Oncology
[14] Istanbul University-Cerrahpasa Medical Faculty,Medical Oncology
[15] Antalya Training and Research Hospital,Medical Oncology
[16] Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital,Medical Oncology
[17] Gulhane Training and Research Hospital,Medical Oncology
[18] Diskapi Yildirim Beyazit Training and Research Hospital,Medical Oncology
[19] Celal Bayar University Medical Faculty,Medical Oncology
[20] Medical Park Samsun Hospital,Medical Oncology
[21] Liv Hospital,Medical Oncology
[22] Sitki Kocman University Medical Faculty,Medical Oncology
[23] Cukurova University Medical Faculty,Medical Oncology
[24] Dicle University Medical Faculty,Medical Oncology
[25] Dokuz Eylul University Medical Faculty,Medical Oncology
[26] Mersin University Medical Faculty,Medical Oncology
[27] Ankara University Medical Faculty,Medical Oncology
[28] Osmaniye State Hospital,Medical Oncology
[29] Medicana Hospital,Medical Oncology
[30] Istanbul Kartal Dr. Lutfi Kirdar Training and Research Hospital,Medical Oncology
[31] Katip Celebi University Atatürk Training and Research Hospital,Medical Oncology
[32] Medical Park Gaziantep Hospital,Medical Oncology
[33] Ordu State Hospital,Medical Oncology
[34] Marmara University Medical Faculty,Medical Oncology, Istinye University Medical Faculty
[35] Antalya Memorial Hospital,Medical Oncology
[36] Liv Hospital,undefined
[37] Necmettin Erbakan University Meram Medical Faculty,undefined
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Atezolizumab; Urothelial carcinoma; Bladder cancer; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1506 / 1513
页数：7
相关论文
共 50 条
  • [1] Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab
    Tural, Deniz
    Olmez, Omer Fatih
    Sumbul, Ahmet Taner
    Ozhan, Nail
    Cakar, Burcu
    Kostek, Osman
    Ekenel, Meltem
    Erman, Mustafa
    Coskun, Hasan Senol
    Selcukbiricik, Fatih
    Keskin, Ozge
    Turkoz, Fatma Paksoy
    Oruc, Kerem
    Bayram, Selami
    Bilgetekin, Irem
    Yildiz, Birol
    Sendur, Mehmet Ali Nahit
    Paksoy, Nail
    Dirican, Ahmet
    Erdem, Dilek
    Selam, Meltem
    Tanriverdi, Ozgur
    Paydas, Semra
    Urakci, Zuhat
    Atag, Elif
    Guncan, Sabri
    Urun, Yuksel
    Alkan, Ali
    Kaya, Ali Osman
    Ozyukseler, Deniz Tataroglu
    Taskaynatan, Halil
    Yildirim, Mustafa
    Sonmez, Muge
    Basoglu, Tugba
    Gunduz, Seyda
    Kilickap, Saadettin
    Artac, Mehmet
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (08) : 1506 - 1513
  • [2] Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab
    Tural, D.
    Olmez, O. F.
    Sumbul, A. T.
    Ozhan, N.
    Akar, E.
    Cakar, B.
    Kostek, O.
    Ekenel, M.
    Erman, M.
    Coskun, H. S.
    Selcukbiricik, F.
    Keskin, O.
    Paksoy, F.
    Oruc, K.
    Bayram, S.
    Yilmaz, U.
    Bilgetekin, I.
    Yildiz, B.
    Sendur, M. A. N.
    Artac, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S598 - S598
  • [3] Atezolizumab for platinum-treated metastatic urothelial carcinoma
    Massari, Francesco
    Di Nunno, Vincenzo
    LANCET, 2018, 391 (10122): : 716 - 718
  • [4] Atezolizumab in invasive and metastatic urothelial carcinoma
    Crist, Michael
    Balar, Arjun
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (12) : 1295 - 1301
  • [5] Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience
    Tural, Deniz
    Olmez, Omer Fatih
    Sumbul, Ahmet Taner
    Artac, Mehmet
    Ozhan, Nail
    Akar, Emre
    Cakar, Burcu
    Kostek, Osman
    Paksoy, Nail
    Erman, Mustafa
    Coskun, Hasan Senol
    Selcukbiricik, Fatih
    Keskin, Ozge
    Turkoz, Fatma Paksoy
    Oruc, Kerem
    Bayram, Selami
    Yilmaz, Ugur
    Bilgetekin, Irem
    Yildiz, Birol
    Kilickap, Saadettin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [6] Novel prognostic factors in metastatic urothelial carcinoma (MUC).
    Palacka, Patrik
    Kucharska, Jarmila
    Mego, Michal
    Luha, Jan
    Sumbalova, Zuzana
    Svetlovska, Daniela
    Rejlekova, Katarina
    Mardiak, Jozef
    Gvozdjakova, Anna
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences
    Tural, Deniz
    Olmez, Omer Fatih
    Sumbul, Ahmet Taner
    Artac, Mehmet
    Ozhan, Nail
    Akar, Emre
    Cakar, Burcu
    Kostek, Osman
    Ekenel, Meltem
    Erman, Mustafa
    Coskun, Hasan Senol
    Selcukbiricik, Fatih
    Keskin, Ozge
    Turkoz, Fatma Paksoy
    Oruc, Kerem
    Bayram, Selami
    Yglmaz, Ugur
    Bilgetekin, Irem
    Ygldgz, Birol
    Sendur, Mehmet Ali Nahit
    Paksoy, Nail
    Dirican, Ahmet
    Erdem, Dilek
    Selam, Meltem
    Tanrgverdi, Ozgur
    Paydas, Semra
    Urakcg, Zuhat
    Atag, Elif
    Guncan, Sabri
    Urun, Yuksel
    Alkan, Ali
    Kaya, Ali Osman
    Ozyukseler, Deniz Tataroglu
    Taskaynatan, Halil
    Ygldgrgm, Mustafa
    Sonmez, Muge
    Basoglu, Tugba
    Gunduz, Seyda
    Kglgckap, Saadettin
    EUROPEAN UROLOGY FOCUS, 2021, 7 (05): : 1061 - 1066
  • [8] Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy
    Hideyuki Abe
    Kohei Takei
    Toshitaka Uematsu
    Yuumi Tokura
    Issei Suzuki
    Kazumasa Sakamoto
    Daisaku Nishihara
    Yoshiyuki Yamaguchi
    Tomoya Mizuno
    Akinori Nukui
    Minoru Kobayashi
    Takao Kamai
    International Journal of Clinical Oncology, 2018, 23 : 338 - 346
  • [9] Prognostic impact of radiological tumor burden in patients with metastatic urothelial carcinoma treated with pembrolizumab
    Katayama, Satoshi
    Iwata, Takehiro
    Kawada, Tasushi
    Okamoto, Yusuke
    Sano, Yuho
    Kawago, Yuya
    Miyake, Shuji
    Moriwake, Takatoshi
    Kuinose, Aya
    Horikawa, Yuhei
    Tsuboi, Kazuma
    Tsuboi, Ichiro
    Sakaeda, Kazuma
    Nakatsuka, Hirokazu
    Takamoto, Atsushi
    Hirata, Takeshi
    Shirasaki, Yoshinori
    Yamasaki, Taku
    Morinaka, Hirofumi
    Nagasaki, Naoya
    Hara, Takafumi
    Ochi, Akinori
    Okumura, Misa
    Watanabe, Tomofumi
    Sekito, Takanori
    Kawano, Kaoru
    Horii, Satoshi
    Yamanoi, Tomoaki
    Nagao, Kentaro
    Yoshinaga, Kasumi
    Maruyama, Yuki
    Tominaga, Yusuke
    Sadahira, Takuya
    Nishimura, Shingo
    Edamura, Kohei
    Kobayashi, Tomoko
    Kusumi, Norihiro
    Kurose, Kyohei
    Yamamoto, Yasuo
    Sugimoto, Morito
    Nakada, Tetsuya
    Sasaki, Katsumi
    Takenaka, Tadasu
    Ebara, Shin
    Miyaji, Yoshiyuki
    Wada, Koichiro
    Kobayashi, Yasuyuki
    Araki, Motoo
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (03) : 70.e11 - 70.e18
  • [10] Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy
    Abe, Hideyuki
    Takei, Kohei
    Uematsu, Toshitaka
    Tokura, Yuumi
    Suzuki, Issei
    Sakamoto, Kazumasa
    Nishihara, Daisaku
    Yamaguchi, Yoshiyuki
    Mizuno, Tomoya
    Nukui, Akinori
    Kobayashi, Minoru
    Kamai, Takao
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (02) : 338 - 346
12345